Name: Latest research reports of Jubilant Pharmova Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Jubilant Pharmova Ltd.
Rating: 3
Author: ICICI Securities Limited

Jubilant Pharmova Ltd.

NSE: JUBLPHARMA | BSE: 530019 | ISIN: INE700A01033 | Industry: Pharmaceuticals
| Strong Performer, Under Radar

914.7500 -4.20 (-0.46%)

NSE Apr 21, 2025 13:34 PM

30.17% Fall from 52W High

Volume: 183.0K

Jubilant Pharmova Ltd.

08 Feb 2022

914.75

-0.46%

Jubilant Pharmova

Hold: Jubilant Pharmova Ltd.

Target

ICICI Securities Limited

Revenue break up (FY21)- Formulations - 24%, Radiopharma and allergy therapy 38% and CDMO & API 33% Q3FY22 Results: Generics and CDMO business were affected due to multiple headwinds leading to reduction in operating leverage....

Jubilant Pharmova Ltd. is trading below its 50 day SMA of 928.2